GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Kimia Farma Tbk (ISX:KAEF) » Definitions » PB Ratio

PT Kimia Farma Tbk (ISX:KAEF) PB Ratio : 0.40 (As of Mar. 24, 2025)


View and export this data going back to 2001. Start your Free Trial

What is PT Kimia Farma Tbk PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-24), PT Kimia Farma Tbk's share price is Rp386.00. PT Kimia Farma Tbk's Book Value per Share for the quarter that ended in Sep. 2024 was Rp957.72. Hence, PT Kimia Farma Tbk's PB Ratio of today is 0.40.

Good Sign:

PT Kimia Farma Tbk stock PB Ratio (=0.48) is close to 10-year low of 0.44

The historical rank and industry rank for PT Kimia Farma Tbk's PB Ratio or its related term are showing as below:

ISX:KAEF' s PB Ratio Range Over the Past 10 Years
Min: 0.4   Med: 2.34   Max: 9.1
Current: 0.4

During the past 13 years, PT Kimia Farma Tbk's highest PB Ratio was 9.10. The lowest was 0.40. And the median was 2.34.

ISX:KAEF's PB Ratio is ranked better than
90.38% of 104 companies
in the Medical Distribution industry
Industry Median: 1.235 vs ISX:KAEF: 0.40

During the past 12 months, PT Kimia Farma Tbk's average Book Value Per Share Growth Rate was -33.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -13.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -0.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 16.00% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of PT Kimia Farma Tbk was 48.30% per year. The lowest was -13.60% per year. And the median was 13.20% per year.

Back to Basics: PB Ratio


PT Kimia Farma Tbk PB Ratio Historical Data

The historical data trend for PT Kimia Farma Tbk's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kimia Farma Tbk PB Ratio Chart

PT Kimia Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.96 3.38 2.33 1.05 1.78

PT Kimia Farma Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 1.78 0.90 0.58 0.88

Competitive Comparison of PT Kimia Farma Tbk's PB Ratio

For the Medical Distribution subindustry, PT Kimia Farma Tbk's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kimia Farma Tbk's PB Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Tbk's PB Ratio distribution charts can be found below:

* The bar in red indicates where PT Kimia Farma Tbk's PB Ratio falls into.



PT Kimia Farma Tbk PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

PT Kimia Farma Tbk's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=386.00/957.722
=0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


PT Kimia Farma Tbk  (ISX:KAEF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


PT Kimia Farma Tbk PB Ratio Related Terms

Thank you for viewing the detailed overview of PT Kimia Farma Tbk's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kimia Farma Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.

PT Kimia Farma Tbk Headlines

No Headlines